Overview

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this trial is to assess the efficacy of reducing plasma low-density lipoprotein(LDL) cholesterol and safety in two different brand drugs, Roty F.C. Tablets 10mg and Crestor 10mg F.C. Tablets in hypercholesterolemia population.
Phase:
N/A
Details
Lead Sponsor:
Pin Siang Medical Biotechnology Co., Ltd.
Treatments:
Rosuvastatin Calcium